19 results
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
principles of insulin ... and Duration #Diabetes ... #Insulin #Analogs ... Peaks #Comparison #Pharmacology ... Endocrinology #Timing #Timeline
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs ... , Duration #Diabetes ... #Insulin #Analogs ... Peaks #Comparison #Pharmacology ... Endocrinology #Timing #Timeline
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
Insulin and analogues ... #pharmacology #table ... comparison #dosing #insulin ... #diabetes #medications ... duration #timing #timeline
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
including most 2 diabetics ... Add sliding scale ... Weight #Based #pharmacology ... endocrinology #diabetes ... #DM2
The graph illustrates the differences in the onset and duration of action for various types of
various types of insulin ... Detemir, Glargine #Diabetes ... #Insulin #Analogs ... Duration #Peaks #Timeline ... Graph #Comparison #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Mellitus #DM2 ... #Medications #pharmacology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Glucophage) 2 INSULIN ... #Management #pharmacology ... #DM2 #DMII #Classification
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... cells, triggering insulin ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
ml/min per 1.73 m2 ... ADA/KDIGO Consensus ... evidence-based pharmacologic ... ADA #KDIGO #eGFR ... #Insulin #metformin
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology